eli lilly weight loss drug zepbound

News

Eli Lilly, weight loss and Big Pharma

Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs

Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular diabetes and weight loss drugs. Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound,

CBS News on MSN · 5d

GLP-1 pill shows success for diabetes, weight loss, Eli Lilly says

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.

Houston Public Media · 11h

Eli Lilly sues Houston-based compounding pharmacy over alleged ‘knockoff’ obesity, diabetes drugs

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA announced that a shortage of Mounjaro and Zepbound had been resolved.

2don MSN

Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

US patients lose access to cheaper weight-loss drugs as market for replicas winds down

Pharmacies told to stop making custom versions of Wegovy and Zepbound after shortages declared officially over ...

13dOpinion

Trump-Powered Medicare Setback Adds Bullish Impetus for Eli Lilly & Co (LLY) Stock

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...

43mon MSN

Is Eli Lilly Stock a Buy?

Eli Lilly ( LLY 1.21%) and Novo Nordisk ( NVO 2.66%) were early leaders in the development of GLP-1 agonists, and dominate the market. Research from MarketsandMarkets suggests that annual global sales ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results